Panel Discussion Pro & Con Covid-19

In March 2026, Moderna paid a record sum of up to $2.25 billion to settle the years-long global patent dispute over the fundamental lipid nanoparticle technology (LNP) with the companies Arbutus Biopharma and Genevant Sciences.

The protective shield principle: Pure mRNA is extremely unstable and would degrade immediately in the human body before reaching the cells. The LNP technology developed by Arbutus encapsulates the mRNA in a tiny fatty layer (lipid nanoparticle) to ensure it can be delivered undamaged into human cells. [

The legal dispute: Arbutus and Genevant sued Moderna because the COVID-19 vaccine Spikevax used their patented LNP mixing ratios without permission.

The billion-dollar verdict (March 2026): Just before the planned jury trial, Moderna agreed to the historic settlement. Moderna will pay $950 million immediately and an additional $1.3 billion depending on a pending appeal. This secured Moderna royalty-free use for future vaccines.

The European Parliament established the COVI special committee to scientifically examine the European lessons from the pandemic and its societal consequences. A central focus of the hearings was reviewing the EU Commission's billion-euro vaccine procurement contracts.

Pfizer CEO Albert Bourla faced sharp criticism for repeatedly refusing to testify personally before the investigative committee.

The hearings revealed a glaring lack of transparency in EU vaccine contracts. The refusal of pharma CEOs to disclose crucial contract details and chat logs drew sharp criticism from lawmakers.

The final report criticized the disproportionate impact of lockdowns on children and adolescents. The hearings clearly showed that school closures and isolation caused severe psychosocial collateral damage and educational deficits.

The uncoordinated border closures within the EU were deemed a political failure. Lawmakers criticized that unilateral actions by individual member states temporarily paralyzed the European single market and freedom of movement without epidemiological benefit.

Experts in the hearings called for stronger democratic oversight of emergency measures. It was noted that far-reaching restrictions on fundamental rights during the pandemic were often decided without involving national parliaments or the EU Parliament.

The findings show that a European Health Union urgently needs more independence. To manage future crises, the committee demands strategic autonomy in pharmaceuticals and an end to global vaccine inequality..

Long-term health effects following a COVID-19 mRNA vaccination are, according to current scientific knowledge (May 2026), rare and occur almost exclusively shortly after administration. Experts distinguish between short-term vaccine reactions and genuine late effects, which would only appear after months; the latter are historically almost unknown with vaccines. A comprehensive French cohort study with 28 million participants confirmed in late 2025 that over a four-year observation period, there was no increased mortality risk among vaccinated individuals aged 18 to 59.

Breakdown in the body: The mRNA is completely broken down within a few days, making the emergence of entirely new diseases years later biologically extremely unlikely.

Post-Vac Syndrome: In very rare cases, persistent symptoms (such as fatigue or dizziness) are described as "Post-Vac Syndrome," but recognition rates by authorities remain low, as a causal link is often difficult to prove.

Myocarditis: Rare cases of myocarditis mostly occurred within the first week after vaccination but, according to long-term observations, usually heal well.

Protective effect: Data from 2026 continue to show that the vaccine significantly reduces the risk of severe outcomes and Long COVID from the infection itself.

Safety monitoring: Institutions such as the Paul-Ehrlich-Institut and Swissmedic continuously monitor suspected cases and, even after more than five years, find no evidence of increased cancer or infertility rates.

In summary, the benefits of vaccination in protecting against organ and long-term damage from the virus far outweigh the minimal risks of the vaccines.

Nanomaterials are often viewed critically in terms of their health effects, as there is concern that they may accumulate in certain organs and trigger inflammatory responses.

A study by the University of Pennsylvania showed that certain LNPs in mRNA vaccines led to damage to cellular endosomes in lab mice, triggering inflammatory responses. Kettner Edelmetalle

New research demonstrates that not all lipid nanoparticles behave the same—their effects on the body vary depending on their composition and are not yet fully understood. Kettner Edelmetalle

With each additional booster dose, the incidence of mRNA vaccine-associated myocarditis could rise—researchers are therefore calling for a more intensive investigation into the role of LNP components in this.

During the transition from clinical to commercial production phases, changes in the manufacturing process were identified, potentially resulting in shortened or altered mRNA strands that could produce incomplete immune responses or unknown protein fragments. TKP

In connection with the BioNTech/Pfizer and Moderna vaccines, rare cases of potentially allergic reactions have been reported, some of which were severe—particularly in individuals with a pre-existing intolerance to PEG (polyethylene glycol), which is contained in the nanoparticles. Landtag

The long-term effects of LNP technology on the human body are not yet fully understood, requiring a more critical examination of the risks and more transparent communication from manufacturers.

The ionizable lipids SM-102 (Moderna) and ALC-0315 (BioNTech/Pfizer) are synthetic, foreign compounds—their long-term compatibility in the human organism was never clinically tested over several years before mass use. ACS Publications

Research into alternative nanoparticle platforms is ongoing—demonstrating that the currently used LNPs are not the optimal solution but rather an early compromise with untapped potential for improvement. Wiley Interdisciplinary Reviews

The rapid development and approval of LNP-based vaccines raise fundamental questions about whether traditional scientific diligence and comprehensive long-term research were sufficiently upheld.

The U.S. Senate is conducting ongoing special hearings to investigate crisis management and the consequences of the pandemic.

A primary focus is on researching the origin of the SARS-CoV-2 coronavirus.

Before the Homeland Security Committee, a CIA whistleblower testified in May 2026 to covered-up evidence of the lab-leak theory.

Republican Senator Rand Paul is aggressively advancing investigations into the Wuhan lab hypothesis.

At the same time, the Senate is intensively examining potential vaccine injuries such as myocarditis.

Health Secretary Robert F. Kennedy Jr. faced sharp questioning over his skeptical vaccine policies.

Democratic senators criticize allegations of a cover-up of side effects as politically motivated and unscientific.

Renowned journals like The Lancet rejected Senate requests for internal documents related to the origin debate.

The hearings have already led to personnel consequences and dismissals at the CDC.

The goal of Congress remains to draw lessons for the safety of future research and trust in federal agencies.

Congress.gov

The Federal Ministry of Health summarizes under the term Long-COVID the long-term health effects that persist weeks or months after an acute SARS-CoV-2 infection.

The most commonly documented symptoms include chronic fatigue, breathing difficulties, cognitive impairments such as brain fog, and persistent muscle and joint pain. The manifestations vary greatly from person to person and, according to medical estimates, affect many organ systems simultaneously, making targeted treatment difficult.

The Robert Koch Institute (RKI) criticized in scientific studies that many studies report excessively high case numbers (prevalence estimates) due to inadequate control groups and inconsistent definitions.

Critics complain about the extremely vague diagnostic criteria, as up to 200 different individual symptoms can be declared as Long-COVID in everyday medical practice.

In the professional world, there is an intense debate about the psychosomatic component of the disease, which often leads to conflicts between somatic medicine, psychiatry, and patient advocacy groups.

Many affected individuals fall into existential distress due to inadequately trained assessors, as applications for disability benefits or care allowances are rejected with reference to misdiagnoses or purely psychological problems.

To this day, there is a lack of reliable, widely validated laboratory diagnostics (biomarkers), which is why the diagnosis can usually only be made through the error-prone exclusion method.

The ongoing debate about the safety and proportionality of Covid-19 measures has led to close, interdisciplinary collaboration among experts. At the center of this movement is the demand for an immediate, worldwide moratorium (halt) on all modRNA-based vaccines. This initiative is supported by a network of Swiss and international lawyers, doctors, and economists who combine their respective expertise to exert legal, health, and economic pressure on authorities and governments.

Medical and scientific risks: Critics such as Swiss lawyer Philipp Kruse or British neuroscientist Dr. Kevin McCairn warn of serious deficiencies in the accelerated approval processes. While official medicine classifies the vaccines as safe, the initiators point to insufficient long-term studies, uncontrolled production of spike proteins in the body, and an alarmingly high rate of reported side effects. Extreme hypotheses from the movement even warn of neurodegenerative damage, which, however, is highly controversial in the international professional community and considered unproven.

Legal and democratic violations: From a legal perspective, it is criticized that state measures (such as lockdowns and certificate requirements) represented unconstitutional infringements on fundamental rights. The authorities allegedly violated their legal duty of care and oversight. Additionally, the increasing transfer of authority to the World Health Organization (WHO) through planned pandemic treaties is criticized as a massive loss of national sovereignty and direct democracy.

Economic misincentives: Economists in the alliance criticize the lack of transparency in government procurement contracts and the pharmaceutical industry's billion-dollar profits. They see this as a misallocation of taxpayer money and a significant financial burden on the healthcare system due to unrecognized treatment costs for alleged vaccine injuries.

mRNA-based COVID-19 vaccines deliver an artificially produced genetic blueprint directly into human body cells.

This injected messenger RNA (mRNA) instructs cells in muscle tissue to produce a specific viral protein for immunization themselves.

The human genome in the protected cell nucleus is demonstrably not altered, as the vaccine mRNA does not enter the cell nucleus and is quickly broken down there.

Many critics complain about the extremely short development and testing time of this novel technology before its worldwide mass approval.

There are ongoing concerns about insufficiently researched long-term or delayed effects that were not systemically foreseeable at the time of approval.

Skeptics regularly point to reports of unwanted vaccine side effects such as myocarditis, which have weakened confidence in the safety of the preparations.

Additionally, reports of DNA contamination from the manufacturing process in some batches sparked loud criticism and health concerns among the public.

The temporary exercise of political and social vaccination pressure is also retrospectively criticized as highly ethically questionable.

Clinical autopsies on deceased COVID-19 patients provided medicine with essential insights into the exact disease mechanisms of the novel virus.

Pathological examinations early on proved that an infection can cause severe vascular damage, microthrombosis, and multi-organ failure.

Through the examined tissue samples, treatment guidelines could be adjusted worldwide, and targeted therapies, such as the early use of blood thinners, were established.

At the beginning of the pandemic, the Robert Koch Institute (RKI) mistakenly recommended largely refraining from autopsies, which cost valuable weeks of scientific analysis.

Independent pathologists vehemently criticized that the total number of officially ordered autopsies remained far too low to achieve complete statistical certainty.

To this day, fierce discussions continue about how clearly the protocols distinguished between people who died "from" or merely "with" SARS-CoV-2.

Additionally, pseudoscientific false claims circulate online, erroneously declaring postmortem blood clots as artificial nanobots or exclusive vaccine injuries ("Calamari Clots").

Expert criticism, however, concerns the insufficient systematic autopsies of suspected cases with severe vaccine complications such as myocarditis, to disclose causalities in a timely and transparent manner.